Anixa Biosciences (ANIX) Gross Margin (2010 - 2012)
Anixa Biosciences (ANIX) posted Gross Margin of -450.00% for fiscal Q4 2012 (quarter ended Oct 31, 2012), down 549.87 percentage points from 99.87% a year earlier and down 549.71 percentage points from the prior quarter.
Powered by 
Analysis
Anixa Biosciences (ANIX) Gross Margin (2010 - 2012) Analysis & Trends
For FY2012 (ended Oct 31, 2012), Anixa Biosciences' Gross Margin came in at 99.59%, up 2.99 percentage points from FY2011.
- In prior fiscal years, Anixa Biosciences' Gross Margin was 96.60% in FY2011 (+7.87 pp) and 88.74% in FY2010.
- The fiscal Q4 2012 figure stands as the lowest quarterly Gross Margin in data going back to fiscal Q3 2010.
- On a year-over-year basis, Gross Margin increased in five of the last six quarters, with an average year-over-year change of -71.78 percentage points.
- According to Business Quant data, Gross Margin for the three prior fiscal quarters was 99.71% (Q3 2012), 99.80% (Q2 2012) and 99.84% (Q1 2012).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 85.78% |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 68.12% |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 74.74% |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 73.54% |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 78.02% |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 83.60% |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 72.04% |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | 79.76% |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 72.78% |
| 10 | Anixa Biosciences | 96.15 Mn | 81.01 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Oct 31, 2012 | -450.00% |
| Jul 31, 2012 | 99.71% |
| Apr 30, 2012 | 99.80% |
| Jan 31, 2012 | 99.84% |
| Oct 31, 2011 | 99.87% |
| Jul 31, 2011 | 99.19% |
| Apr 30, 2011 | 71.64% |
| Jan 31, 2011 | 69.30% |
| Oct 31, 2010 | 97.67% |
| Jul 31, 2010 | 41.40% |
API Access
Anixa Biosciences Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=ANIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "ANIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=ANIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();